ロード中...
Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.
BACKGROUND--A recent double blind clinical trial in Japan has shown that auranofin (6 mg/day) is a useful treatment for patients with moderate to severe asthma. To investigate the mechanism of action of auranofin the bronchial responsiveness to inhaled methacholine has been studied in well controlle...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1994
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC475050/ https://ncbi.nlm.nih.gov/pubmed/8066558 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|